Filing Details
- Accession Number:
- 0001127602-14-023797
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-07-24 16:43:47
- Reporting Period:
- 2014-07-22
- Filing Date:
- 2014-07-24
- Accepted Time:
- 2014-07-24 16:43:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1275654 | P David King | 531 South Spring Street Burlington NC 27215 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-07-22 | 65,233 | $75.63 | 120,816 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-22 | 63,633 | $105.54 | 57,183 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-07-22 | 1,600 | $105.99 | 55,583 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Options | Disposition | 2014-07-22 | 65,233 | $0.00 | 65,233 | $75.63 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
130,467 | 2009-05-07 | 2018-05-07 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 31,223 | Indirect | By grantor retained annuity trust |
Common Stock | 27,296 | Indirect | By grantor retained annuity trust |
Footnotes
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- Amount includes 196.7958 shares acquired on June 30, 2014 under the Laboratory Corporation of America Holdings 1997 Employee Stock Purchase Plan, as amended. Amount also includes annuity payments made in shares of common stock from one of the reporting person's grantor retained annuity trusts to the reporting person in the amounts and on the dates indicated in note (5) below, and reflects the transfer of shares of common stock to the other of the reporting person's grantor retained annuity trusts described in note (6) below.
- The price of $105.5400 per share represents a weighted average of sales prices ranging from $104.91 to $105.90 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- The price of $105.9900 per share represents a weighted average of sales prices ranging from $105.91 to $106.07 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Amount reflects annuity payments of 5,924 shares and 6,611 shares made by the trust to the reporting person on August 22, 2013 and July 21, 2014 respectively.
- On July 16, 2014, the reporting person contributed 27,296 shares of common stock to a grantor retained annuity trust for the benefit of certain of his family members and for which the reporting person is the annuitant. The reporting person is the trustee of the trust.
- Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
- The option vested in three equal annual installments beginning on 05/7/2009 and is now fully exercisable.